Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A new lead to NLRP3 inhibition

23 Oct 2017

Abstract excerpt

The discovery of a small molecule inhibitor that targets the inflammasome sensor NLRP3 offers a new path for the development of selective inflammasome blockers with potential therapeutic benefit in a wide range of human diseases (in this issue, see Jiang et al., https://doi.org/10.1084/jem.20171419).

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoimmune and Inflammatory Disorders Research
Share to Gout, Hyperuricemia, Uric Acid
Share to Inflammasome and immune disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29061692
DOI: 10.1084/jem.20171848

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A new lead to NLRP3 inhibitionPMID 29061692Read ↗

Anti-NLRP3 Inflammasome Natural Compounds: An UpdateSemantic proximity Read ↗

The NLRP3 Inflammasome as a Pharmacological TargetSemantic proximity Read ↗

Specific NLRP3 inflammasome inhibitors: promising therapeutic agents for inflammatory diseasesSemantic proximity Read ↗

Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disordersSemantic proximity Read ↗

A patent review of NLRP3 inhibitors to treat autoimmune diseasesSemantic proximity Read ↗

Promise of the NLRP3 Inflammasome Inhibitors in In Vivo Disease ModelsSemantic proximity Read ↗

Discovery of a Potent and Selective Inhibitor of Human NLRP3 with a Novel Binding Modality and Mechanism of ActionSemantic proximity Read ↗

A phenotypic high-content, high-throughput screen identifies inhibitors of NLRP3 inflammasome activation.Semantic proximity Read ↗

Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectivesSemantic proximity Read ↗

Regulation of the NLRP3 Inflammasome by Post-Translational Modifications and Small MoleculesSemantic proximity Read ↗

NLRP3 inflammasome in cancer and metabolic diseasesSemantic proximity Read ↗

A detailed Molecular Network Map and Model of the NLRP3 InflammasomeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.